08/05/2025
3:53 PM | Vera Therapeutics (Filer)
| Form 424B5 | |
08/05/2025
6:30 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2025
7:07 PM | ENRIGHT PATRICK G (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:38 PM | Flynn James E (Filed by)
Vera Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/03/2025
5:36 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
5:36 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
7:00 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
3:44 PM | Vera Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2025
3:21 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025
7:00 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2025
3:05 PM | JOHNSON DAVID LEE (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VERA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/20/2025
3:07 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
3:08 PM | Grant Sean (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
3:10 PM | Brenner Robert (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
8:30 AM | Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025
7:06 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
3:22 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
3:24 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
3:59 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
3:05 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:40 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
11:15 AM | Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
8:35 AM | Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
7:00 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
6:49 PM | Longitude Capital Partners IV, LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13D/A | |
10/31/2024
5:05 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:15 PM | Vera Therapeutics (Filer)
| Form 424B5 | |
10/29/2024
5:15 AM | Vera Therapeutics (Filer)
| Form 424B5 | |
10/28/2024
4:29 PM | Vera Therapeutics (Filer)
| Form S-3ASR | |
10/28/2024
4:30 PM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:37 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
3:16 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:05 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
3:17 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
8:01 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:05 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:45 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:38 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:38 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:36 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad) The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million.
Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant. See his full breakdown of the seven stocks to own now |
09/11/2024
3:19 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:04 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:40 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:31 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:24 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
3:36 PM | Vera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:00 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
